Waterloo Capital’s Medpace MEDP Stock Holding History

Waterloo Capital’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-366	Closed	-$206K	–	509
2025 Q4	$206K	Buy	+366	New	+$208K	0.01%	445

Other funds holding MEDP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Waterloo Capital's MEDP Position: Q1 2026 in Review

Waterloo Capital sold out of Medpace (MEDP) in Q1 2026, closing a stake of 366 shares — an estimated $206K sold.

Waterloo Capital first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $206K in Q4 2025. 729 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Waterloo Capital reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Waterloo Capital sold 366 Medpace shares in Q1 2026, an estimated $206K.
Waterloo Capital first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
Waterloo Capital's Medpace position peaked at $206K in Q4 2025.
729 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Waterloo Capital's 13F filing for Q1 2026, filed 12 May 2026.